Abstract
Inhaled corticosteroids (ICS) have been recommended for use in patients with chronic obstructive pulmonary disease (COPD) in order to decrease exacerbation rates and improve health related quality of life parameters. Nevertheless, recent studies have reported an increased risk of pneumonia associated with this treatment. However, most studies were not specifically designed to detect pneumonia as a possible secondary effect and for this reason it is difficult to determine whether this risk exists and assess its magnitude. This paper reviews the published studies reporting pneumonia events in COPD patients treated with ICS.
Keywords: Chronic obstructive pulmonary disease, pneumonia, inhaled corticosteroids
Current Respiratory Medicine Reviews
Title: Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease
Volume: 6 Issue: 3
Author(s): Rosa Malo de Molina, Marcos I. Restrepo, Eric M. Mortensen, Jose L. Izquierdo and Antonio Anzueto
Affiliation:
Keywords: Chronic obstructive pulmonary disease, pneumonia, inhaled corticosteroids
Abstract: Inhaled corticosteroids (ICS) have been recommended for use in patients with chronic obstructive pulmonary disease (COPD) in order to decrease exacerbation rates and improve health related quality of life parameters. Nevertheless, recent studies have reported an increased risk of pneumonia associated with this treatment. However, most studies were not specifically designed to detect pneumonia as a possible secondary effect and for this reason it is difficult to determine whether this risk exists and assess its magnitude. This paper reviews the published studies reporting pneumonia events in COPD patients treated with ICS.
Export Options
About this article
Cite this article as:
Malo de Molina Rosa, I. Restrepo Marcos, M. Mortensen Eric, L. Izquierdo Jose and Anzueto Antonio, Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526229
DOI https://dx.doi.org/10.2174/157339810791526229 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plasma Cytokine Levels in Overweight Versus Obese Disease-Free Perimenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Scopolamine and Depression: A Role for Muscarinic Antagonism?
CNS & Neurological Disorders - Drug Targets Thermal-Assisted Refolding: Dilution Folding Initiated at High Temperature
Current Pharmaceutical Biotechnology EDITORIAL (Thematic Issue: Serpins as Therapeutics – A Potential Biologic Source for Unique Protein-based Therapeutics)
Cardiovascular & Hematological Disorders-Drug Targets Cytokine-Directed Therapy in Asthma
Current Drug Targets - Inflammation & Allergy Secretoneurin: A New Player in Angiogenesis and Chemotaxis Linking Nerves, Blood Vessels and the Immune System
Current Protein & Peptide Science Anti-Inflammatory, Analgesic and Anti-Nociceptive Efficacy of Peel of <i>Abelmoschus esculentus</i> Fruits in Laboratory Animal
Current Drug Therapy Mechanical Stimulation Protocols of Human Derived Cells in Articular Cartilage Tissue Engineering – A Systematic Review
Current Stem Cell Research & Therapy The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory Response
Current Molecular Pharmacology Immunogenicity, Immunopathogenicity, and Immunotolerance in One Graph
Anti-Cancer Agents in Medicinal Chemistry Update on Pharmacologic Retinal Vascular Toxicity
Current Pharmaceutical Design The Animal Models of Dementia and Alzheimer’s Disease for Pre-Clinical Testing and Clinical Translation
Current Alzheimer Research Promotion of Optimized Protein Therapy by Bioconjugation as a Polymeric DDS
Anti-Cancer Agents in Medicinal Chemistry Treatment of Hepatitis C Cirrhotic Patients With Directly Acting Antivirals: A Multicenter Study
Infectious Disorders - Drug Targets Bioinformatics Approach for Data Capturing: The Case of Breast Cancer
Current Cancer Therapy Reviews Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Current Medicinal Chemistry S100A8/A9 as a Pro-inflammatory Cytokine in Obstructive Airway Disease Via the Multi-Ligand Receptor, RAGE
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Montelukast Sodium Formulation Containing Green Tea Extract to Reduce the Oxidative Stress in Guinea Pig Model of Chronic Allergic Asthma
Recent Patents on Drug Delivery & Formulation In Vivo Target Validation: Methodology and Case Studies on the Janus Kinase Tyk2
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment
Recent Patents on Drug Delivery & Formulation